Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Longsheng Group is a diversified global chemical conglomerate primarily recognized as a world leader in the production of dyestuffs and specialty chemicals. The company maintains a significant presence in the life sciences industry by manufacturing a wide range of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) used in small molecule drug synthesis. Headquartered in China and listed on the Shanghai Stock Exchange, Longsheng leverages its large-scale chemical manufacturing capabilities to serve the global pharmaceutical supply chain. Its business model focuses on high-volume production and vertical integration within the specialty chemical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Longsheng Group.